TP-1287
TP-1287, a prodrug of Alvocidib , is an orally active CDK9 inhibitor[1].
Product Specifications
CAS Number
2044686-42-0
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tp-1287.html
Purity
95.10
Solubility
DMSO : 10 mg/mL (ultrasonic; warming; heat to 60°C) |Methanol : 125 mg/mL (ultrasonic)
Smiles
O=P(O)(O)OC1=CC(O)=C(C(C=C(C2=C(C=CC=C2)Cl)O3)=O)C3=C1[C@@H]4[C@@H](CN(CC4)C)O
Molecular Formula
C21H21ClNO8P
Molecular Weight
481.82
References & Citations
[1]Tyagi E, et al. The Oral CDK9 Inhibitor, TP-1287, Is Active in Non-Clinical Models of Multiple Myeloma. Blood, 2018, 132: 3269.|[2]Kim W, et al. TP-1287, an oral prodrug of the cyclin-dependent kinase-9 inhibitor alvocidib. Cancer Research, 2017, 77 (13_Supplement) : 5133-5133.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
CDK9
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
G5674 96 Tests
Putative uncharacterized protein C19orf73 (C19orf73) Human ELISA Kit
Sign In for Pricing
View Details 
250966-ML405 100 µL
RBP4 (Retinol Binding Protein 4, Plasma) (MaxLight 405) discontinued
Sign In for Pricing
View Details 